DNASENSE ApS: Financial statements 2025
CVR: 36036869
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
DNASENSE ApS (CVR 36036869) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 7,915,337 and a net result of DKK 894,729. Equity in the 2025 report amounted to DKK 1,639,012. The solvency ratio was 15.8%. The company had 7 employees in the financial year.
- Gross Profit
- DKK 7,915,337
- Profit/Loss
- DKK 894,729
- Equity
- DKK 1,639,012
- Total Assets
- DKK 10,378,324
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 7.9 mio. | 895 t. | 1.6 mio. | 7 |
| 2023 | - | 4.5 mio. | 550 t. | 802 t. | 7 |
| 2022 | - | 4.3 mio. | 867 t. | 852 t. | 6 |
| 2021 | - | 3 mio. | 78 t. | -15 t. | 5 |
| 2020 | - | 1.4 mio. | -1.1 mio. | -93 t. | 5 |
Official annual report
How creditworthy is DNASENSE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
DNASENSE ApS has published its interim report for the period October 1, 2023 – December 31, 2024.
As of February 19, 2025, Anders Mohr Christensen has joined the board of directors of DNASENSE ApS.
About DNASENSE ApS
DNASENSE ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mads Toft Søndergaard. The board consists of Anders Christian Neto de Sousa Grøn (chair), Anders Mohr Christensen, Henrik Bjørn Nielsen and Manoj Nirmal Dadlani. The company is owned by Clinical-Microbiomics A/S. The company has 15 employees (2018). In 2025, the company reported a gross profit of DKK 7,915,337 and a net result of DKK 894,729. Equity in the 2025 report amounted to DKK 1,639,012.